Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Dr Adrián Povo Retana, CSIC, Spain

Dr. Adrián Povo Retana is a distinguished postdoctoral researcher at the Instituto de Investigaciones Biomédicas Alberto Sols 🏥🔬. With expertise in immunometabolism, biomedicine, and molecular biology, his research focuses on immune modulation in diseases like cancer and cardiovascular conditions 🧬💉. He earned his Ph.D. in Biociencias Moleculares from the Universidad Autónoma de Madrid 🎓 in 2022, after completing a Master’s in Biochemistry, Molecular Biology, and Biomedicine at Universidad Complutense de Madrid. His pioneering studies explore novel immunomodulatory therapies, and he actively supervises Ph.D. students 👨‍🏫📚. A key contributor to R&D projects, he investigates therapeutic applications of calcifediol in lymphoma and heart disease ❤️. As an author of high-impact publications and a collaborator on competitive research projects, his work advances cutting-edge biomedical treatments. His dedication to scientific excellence makes him a strong candidate for the Best Researcher Award 🏅🔍.

Publication Profile

Scopus

Education 🎓

  • Doctorate in Biociencias Moleculares (Ph.D.) 🧬🔬
    • Institution: Universidad Autónoma de Madrid
    • Graduation Date: 18/11/2022
  • Master’s in Biochemistry, Molecular Biology, and Biomedicine 🏥🧪
    • Institution: Universidad Complutense de Madrid
    • Graduation Date: 20/07/2017
  • Graduado en Biotecnología (Bachelor’s in Biotechnology) 🧫🧑‍🔬
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015
  • Título Propio in Research Methodology in Biotechnology 📊🔍
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015

Experience

  • Postdoctoral Researcher 🏥🔍
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 18/11/2022 – Present
  • Predoctoral Researcher 📖🧪
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 15/06/2017 – 17/11/2022 (5 years, 5 months)

🔹 Supervision of Ph.D. Theses 🎓📚

  • “Immunomodulatory Effects of Ecteinascidins” – Universidad Autónoma de Madrid (2024)
  • “Vitamin D and FICZ Role in Immune Regulation” – Universidad Autónoma de Madrid (2024)
  • “Effect of 25-OH-D in Human Cell Cultures” – Universidad Complutense de Madrid (2023)

Awards & Honors

Recipient of the prestigious Chinese Government Scholarship, Dr. Adrián Povo Retana has established a remarkable academic and research career. Their dedication to innovation and scientific excellence earned them a nomination for the Best Young Researcher Award 🏅, highlighting their contributions to cutting-edge research. Securing multiple competitive research grants 💰, they have led impactful projects that drive advancements in their field. As a contributing author in high-impact journals 📄, their work has gained international recognition. Additionally, serving as a key investigator in major R&D projects 🔬, they play a crucial role in pioneering discoveries and technological advancements. Their commitment to academic excellence and research leadership continues to shape the future of science. 🌟

Research Focus

Dr. Adrián Povo Retana’s research revolves around immunometabolism, biomedicine, and immune system modulation 🏥🧬. His studies focus on the role of Vitamin D and nuclear receptors (VDR and AhR) in immune responses, particularly in cancer therapy and cardiovascular diseases ❤️💉. He investigates the immunomodulatory actions of compounds like trabectedin and lurbinectedin, contributing to novel therapeutic strategies against inflammation-related diseases. His work in macrophage and T-cell metabolism has led to new insights into anti-inflammatory treatments 🦠🔬. As a principal investigator in multiple state-funded R&D projects, he explores the therapeutic potential of calcifediol in lymphoma and myocardial infarction. His groundbreaking research continues to shape the future of immunotherapy and molecular medicine 🚀🩺.

Publication Top Notes

1️⃣ “Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm” – Advanced Healthcare Materials, 2024
2️⃣ “Immunometabolic Actions of Trabectedin and Lurbinectedin on Human Macrophages: Relevance for Their Anti-Tumor Activity” – Frontiers in Immunology, 2023

 

 

Ahmad Daryani | Microbiology | Most Reader’s Article Award

Posted on by ScienceFather

Prof. Ahmad Daryani | Microbiology | Most Reader’s Article Award

 

Professor of University at Mazandaran University of Medical Sciences, Iran

Prof. Ahmad Daryani is a distinguished researcher and academic with a robust background in parasitology and public health. He holds a Bachelor’s degree in Public Health from Iran University of Medical Sciences (1990), an M.Sc. in Parasitology from Tarbiat Modarres University (1994), and a Ph.D. in Parasitology from the same institution (2000). Prof. Daryani has led numerous research projects, significantly contributing to the understanding of parasitic infections and their public health implications. His studies include the prevalence of intestinal parasites in Ardabil city, the prevalence of parasitic infections among primary school students, and surveys on Sarcocystis infection in sheep and buffaloes. He has also focused on the seroepidemiology of toxoplasmosis in women and the immune responses against antigens of Toxoplasma gondii in a murine model.

Professional Profiles:

📚 Education:

Prof. Ahmad Daryani has an extensive educational background in the field of medical sciences and parasitology. He earned his Bachelor’s degree in Public Health from Iran University of Medical Sciences in 1990. Following this, he pursued a Master’s degree in Parasitology at Tarbiat Modarres University, graduating in 1994. Continuing his advanced studies in the same institution, Prof. Daryani completed his Ph.D. in Parasitology in 2000. His academic journey highlights his dedication and expertise in public health and parasitology.

Research:

Prof. Ahmad Daryani has conducted several significant research projects focusing on parasitic infections and public health. His projects include a study on the prevalence of intestinal parasites in a healthy village in Ardabil city, Iran, before environmental sanitation was implemented. He also investigated the prevalence of intestinal parasitic infections among primary school students in Ardabil. His research extended to a survey of Sarcocystis infection in slaughtered sheep and buffaloes in Ardabil and a seroepidemiology study of toxoplasmosis in women referred to the Ardabil laboratory of the health center for medical examinations before marriage. Additionally, Prof. Daryani explored immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in a murine model. He conducted a study on the prevalence of hydatid cysts in slaughtered animals in Ardabil and another seroepidemiology study of toxoplasmosis in Roudsar city. He also examined the prevalence of Blastocystis hominis infection in primary school children in Ardabil. Furthermore, he assessed the fertility and viability rate of protoscoleces of hydatid cysts in sheep and cattle slaughtered in Ardabil. These projects underscore his dedication to understanding and addressing parasitic infections and their impact on public health.

 

📚Publications :

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis

Authors: SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, …

Citations: 9043

Year: 2018

Journal: The Lancet 392 (10159), 1789-1858

2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Authors: T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, …

Citations: 7502

Year: 2020

Journal: The Lancet 396 (10258), 1204-1222

3. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015

Authors: C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, …

Citations: 7167

Year: 2017

Journal: JAMA Oncology 3 (4), 524-548

4. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, …

Citations: 6848

Year: 2018

Journal: The Lancet 392 (10159), 1736-1788

5. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, …

Citations: 5966

Year: 2018

Journal: The Lancet 392 (10159), 1923-1994

6. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Authors: CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, …

Citations: 5790

Year: 2020

Journal: The Lancet 396 (10258), 1223-1249

7. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: B Bikbov, CA Purcell, AS Levey, M Smith, A Abdoli, M Abebe, …

Citations: 4587

Year: 2020

Journal: The Lancet 395 (10225), 709-733

8. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, …

Citations: 3928

Year: 2018

Journal: The Lancet 392 (10159), 1859-1922

9. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Authors: MG Griswold, N Fullman, C Hawley, N Arian, SRM Zimsen, HD Tymeson, …

Citations: 3050

Year: 2018

Journal: The Lancet 392 (10152), 1015-1035

10. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Authors: CO Johnson, M Nguyen, GA Roth, E Nichols, T Alam, D Abate, …

Citations: 2496

Year: 2019

Journal: The Lancet Neurology 18 (5), 439-458

11. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Authors: VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, …

Citations: 2473

Year: 2019

Journal: The Lancet Neurology 18 (5), 459-480

12. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, …

Citations: 1751

Year: 2020

Journal: The Lancet Gastroenterology & Hepatology 5 (1), 17-30

13. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Authors: JB Soriano, PJ Kendrick, KR Paulson, V Gupta, EM Abrams, RA Adedoyin, …

Citations: 1443

Year: 2020

Journal: The Lancet Respiratory Medicine 8 (6), 585-596